Oxford Asset Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Oxford Asset Management’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-54,626	Closed	-$68K	–	2058
2019 Q2	$68K	Sell	54,626 -80,434	-60%	-$102K	﹤0.01%	1631
2019 Q1	$194K	Sell	135,060 -89,423	-40%	-$133K	﹤0.01%	1516
2018 Q4	$265K	Buy	224,483 +199,312	+792%	+$296K	0.01%	1447
2018 Q3	$35K	Sell	25,171 -16,008	-39%	-$25.4K	﹤0.01%	1661
2018 Q2	$95K	Buy	+41,179	New	+$79.5K	﹤0.01%	1639
2018 Q1	–	Sell	-58,234	Closed	-$45K	–	1992
2017 Q4	$45K	Sell	58,234 -28,583	-33%	-$25.6K	﹤0.01%	1568
2017 Q3	$100K	Sell	86,817 -9,642	-10%	-$12.2K	﹤0.01%	1473
2017 Q2	$168K	Sell	96,459 -62,647	-39%	-$133K	﹤0.01%	1377
2017 Q1	$420K	Buy	159,106 +119,134	+298%	+$428K	0.01%	1103
2016 Q4	$170K	Buy	+39,972	New	+$132K	0.01%	711
2015 Q4	–	Sell	-42,467	Closed	-$260K	–	988
2015 Q3	$260K	Sell	42,467 -32,739	-44%	-$222K	0.01%	560
2015 Q2	$496K	Sell	75,206 -126,963	-63%	-$856K	0.01%	530
2015 Q1	$1.44M	Buy	+202,169	New	+$1.52M	0.04%	405

Other funds holding GEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oxford Asset Management's GEN Position: Q3 2019 in Review

Oxford Asset Management sold out of Genesis Healthcare, Inc. (GEN) in Q3 2019, closing a stake of 54,626 shares — an estimated $68K sold.

Oxford Asset Management first reported a position in GEN in Q1 2015 and held it in 13 quarters. The position peaked at $1.44M in Q1 2015. 74 funds tracked by Wall St. Rank hold GEN as of Q3 2019.

Oxford Asset Management reported no remaining Genesis Healthcare, Inc. position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 54,626 Genesis Healthcare, Inc. shares in Q3 2019, an estimated $68K.
Oxford Asset Management first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 13 quarters.
Oxford Asset Management's Genesis Healthcare, Inc. position peaked at $1.44M in Q1 2015.
74 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.